Roivant Sciences (ROIV) Receivables - Accured (2023 - 2026)

Roivant Sciences (ROIV) has 4 years of Receivables - Accured data on file, last reported at $19.6 million in Q1 2026.

• Quarterly Receivables - Accured rose 61.98% year-over-year to $19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 61.98% YoY) and the FY2026 annual result came in at $19.6 million, up 61.98% from the prior year.
• Receivables - Accured grew to $19.6 million in Q1 2026, from $12.1 million in the prior quarter.
• In the past five years, Receivables - Accured ranged from a high of $27.4 million in Q1 2024 to a low of $4.9 million in Q1 2023.
• A 4-year average of $17.8 million and a median of $19.3 million in 2023 frame the typical range for Receivables - Accured.
• Annual changes were most pronounced in 2024 — Receivables - Accured jumped 458.99% — and 2025, when it sank 55.91%.
• Tracing ROIV's Receivables - Accured over 4 years: stood at $18.9 million in 2023, then grew by 22.68% to $23.2 million in 2024, then slumped by 47.82% to $12.1 million in 2025, then jumped by 61.98% to $19.6 million in 2026.
• The last three Receivables - Accured figures came in at $19.6 million (Q1 2026), $12.1 million (Q1 2025), and $23.2 million (Q4 2024), per Business Quant data.